Effect analysis of levofloxacin combined with azithromycin in the treatment of chronic cervicitis
左氧氟沙星联合阿奇霉素治疗慢性宫颈炎的效果分析

摘要

目的 分析探究慢性宫颈炎患者治疗中采取左氧氟沙星联合阿奇霉素治疗的效果。方法 46例研究对象为本院于2020年2月-2021年2月期间收治的慢性宫颈炎患者。将上述研究对象采取信封抽签法进行分组，其中一种设定为对照组，此组所采取的治疗方法为阿奇霉素治疗，另一组设定为实验组，本组采取的治疗方法为左氧氟沙星联合阿奇霉素治疗，每组皆有23例患者。为了验证左氧氟沙星联合阿奇霉素治疗慢性宫颈炎的效果，本次研究以治疗有效率、症状评分、炎症介质指标以及不良反应发生率方面予以评价。结果 实验组的治疗有效率和对照组进行了比较，结果可见实验组较高（P＜0.05）。实验组的症状评分和对照组进行了对比，结果可见，治疗前两组对比差异无法满足统计学含义（P＞0.05），治疗后实验组相比较对照组较低（P＜0.05）。实验组炎症介质指标和对照组进行了比较，结果可见，治疗前两组对比差异无法满足统计学含义（P＞0.05），治疗后实验组相比较对照组较低（P＜0.05）。实验组的不良反应发生率和对照组进行比较，结果可见实验组相对较低（P＜0.05）。结论 在慢性宫颈炎患者治疗中施行左氧氟沙星联合阿奇霉素治疗，可显著提升患者的治疗有效率，改善患者的相关症状以及炎症介质指标，同时具有较高的治疗安全性，减少不良反应的产生。由此看来，此种联合治疗方法在慢性宫颈炎患者的治疗中具有重要的意义。

Abstract

Objective To analyze the effect of levofloxacin combined with azithromycin in the treatment of patients with chronic cervicitis.
Methods A total of 46 subjects were patients with chronic cervicitis admitted to our hospital from February 2020 to February 2021. The above research subjects were divided into groups by envelope drawing method, one of them was set as the control group, the treatment method adopted in this group was azithromycin treatment, and the other group was set as the experimental group, and the treatment method adopted in this group was levofloxacin combined with azithromycin. There were 23 patients in each group. In order to verify the effect of levofloxacin combined with azithromycin in the treatment of chronic cervicitis, this study evaluated the treatment efficiency, symptom score, inflammatory mediator indicators and incidence of adverse reactions.
Results The therapeutic efficiency of the experimental group was compared with that of the control group, and the results showed that the experimental group was higher (P<0.05). The symptom scores of the experimental group were compared with those of the control group. The results showed that the difference between the two groups before treatment could not meet statistical significance (P>0.05), and the experimental group was lower than the control group after treatment (P<0.05). The inflammatory mediator indicators in the experimental group were compared with those in the control group. The results showed that the difference between the two groups before treatment could not meet statistical significance (P>0.05), and the experimental group was lower than the control group after treatment (P<0.05). The incidence of adverse reactions in the experimental group was compared with that in the control group, and the results showed that the experimental group was relatively lower (P<0.05).
Conclusion   The combination of levofloxacin and azithromycin in the treatment of patients with chronic cervicitis can significantly improve the patient's treatment efficiency, improve the patient's related symptoms and inflammatory mediator indicators, and at the same time has high treatment safety and reduce the occurrence of adverse reactions. From this point of view, this combined treatment method is of great significance in the treatment of patients with chronic cervicitis.